MANNKIND CORP — Director's Dealing 2024

Feb 5, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MANNKIND CORP (MNKD)
CIK: 0000899460
Period of Report: 2023-12-31

Reporting Person: BLANK BURKHARD (EVP Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-31	Common Stock, $0.01 Par Value	A	5000	$3.09	Acquired	215000	Direct
2024-02-04	Common Stock, $0.01 Par Value	A	152905	$3.27	Acquired	367905	Direct

Footnotes

F1: Includes 5000 shares of common stock purchased under the Company's Employee Stock Purchase Plan on December 31, 2023 in an exempt transaction.

F2: The securities were purchased through the Issuer's Market Price Stock Purchase Plan effective May 13, 2023. The purchase was approved by the Company's Board of Directors on February 4, 2024.